Avisa Diagnostics Inc.
A breath biomarker company developing a rapid, point-of-care test to detect pulmonary infections.
Avisa Diagnostics Inc. (AVBT)
le 6 décembre/December 2021
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.